(Q33844763)

29 July 2017

1 reference

title

A potential role for creatine in drug abuse? (English)

1 reference

29 July 2017

Kristen E D'Anci

1

1 reference

29 July 2017

Patricia J Allen

series ordinal

2

1 reference

29 July 2017

Robin B Kanarek

series ordinal

3

1 reference

29 July 2017

publication date

12 March 2011

1 reference

29 July 2017

published in

Molecular Neurobiology

1 reference

29 July 2017

volume

44

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

136-141

1 reference

Functions and effects of creatine in the central nervous system.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Exploring the therapeutic role of creatine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Chronic creatine supplementation alters depression-like behavior in rodents in a sex-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine monohydrate in resistant depression: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Synthesis and transport of creatine in the CNS: importance for cerebral functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine metabolism and the consequences of creatine depletion in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine: endogenous metabolite, dietary, and therapeutic supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Relating structure to mechanism in creatine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine protects the central respiratory network of mammals under anoxic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine supplementation improves dopaminergic cell survival and protects against MPP+ toxicity in an organotypic tissue culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine treatment promotes differentiation of GABA-ergic neuronal precursors in cultured fetal rat spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Mitochondrial involvement in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

On the mechanisms of neuroprotection by creatine and phosphocreatine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine and cyclocreatine attenuate MPTP neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Dietary supplementation with creatine monohydrate prevents corticosteroid-induced attenuation of growth in young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Magnetic resonance spectroscopy: current and future applications in psychiatric research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Brain metabolic alterations in medication-free patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Serum creatine kinase level in unmedicated nonpsychotic, psychotic, bipolar and schizoaffective depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Methamphetamine- and trauma-induced brain injuries: comparative cellular and molecular neurobiological substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Prevention of traumatic headache, dizziness and fatigue with creatine administration. A pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine-enhanced diet alters levels of lactate and free fatty acids after experimental brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Attentional control and brain metabolite levels in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Separate and interactive effects of cocaine and alcohol dependence on brain structures and metabolites: quantitative MRI and proton MR spectroscopic imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

1H MRS-detectable metabolic brain changes and reduced impulsive behavior in adult rats exposed to methylphenidate during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Review: The neuropathology of drug abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Cerebral energetic effects of creatine supplementation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine supplementation lowers brain glutamate levels in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-011-8176-2

Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood

21 January 2018

1 reference

12 December 2020

Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users

1 reference

12 December 2020

Dietary supplement creatine protects against traumatic brain injury

1 reference

12 December 2020

The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain

1 reference

12 December 2020

Creatine and creatinine metabolism

1 reference

12 December 2020

Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier.

1 reference

12 December 2020

Impaired brain creatine kinase activity in Huntington's disease.

1 reference

12 December 2020

Cloning, pharmacological characterization, and genomic localization of the human creatine transporter

1 reference

12 December 2020

Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.

1 reference

12 December 2020

Increase of total creatine in human brain after oral supplementation of creatine-monohydrate

1 reference

12 December 2020

Methyl balance and transmethylation fluxes in humans.

1 reference

12 December 2020

Mitochondrial dysfunction and psychiatric disorders

1 reference

12 December 2020

Creatinine and creatine in CSF: indices of brain energy metabolism in depression. Short note

1 reference

12 December 2020

Open study of creatine monohydrate in treatment-resistant posttraumatic stress disorder.

1 reference

12 December 2020

Transcription of the brain creatine kinase gene in glial cells is modulated by cyclic AMP-dependent protein kinase

1 reference

12 December 2020

10.1007/S12035-011-8176-2

Identifiers

DOI

1 reference

Dimensions Publication ID

29 July 2017

1028871898

0 references

1 reference